Table 3 Classes of carcinomas used for random forest prediction of cancer types
Class name | TCGA cohorts | Sample size | ||
|---|---|---|---|---|
Total | Training set | Test set | ||
Adrenal gland | Adrenocortical carcinoma (ACC) | 271 | 179 | 92 |
Pheochromocytoma and paraganglioma (PCPG) | ||||
Bladder | Urothelial carcinoma (BLCA) | 411 | 272 | 139 |
Brain | Lower grade glioma (LGG) | 515 | 340 | 175 |
Breast | Breast invasive carcinoma (BRCA) | 1077 | 711 | 366 |
Gastrointestinal | Esophageal carcinoma (ESCA) | 1237 | 817 | 420 |
Stomach adenocarcinoma (STAD) | ||||
Colon adenocarcinoma (COAD) | ||||
Rectum adenocarcinoma (READ) | ||||
Cholangiocarcinoma (CHOL) | ||||
Head & Neck | Head and neck squamous cell carcinoma (HNSC) | 590 | 390 | 200 |
Uveal melanoma (UVM) | ||||
Hematologic | Acute myeloid leukemia (LAML) | 321 | 212 | 109 |
Diffuse large B-cell lymphoma (DLBC) | ||||
Thymoma (THYM) | ||||
Kidney | Kidney Chromophobe (KICH) | 738 | 488 | 250 |
Renal clear cell carcinoma (KIRC) | ||||
Renal papillary cell carcinoma (KIRP) | ||||
Liver | Hepatocellular carcinoma (LIHC) | 321 | 212 | 109 |
Ovary | Ovarian serous cystadenocatcinoma (OV) | 437 | 289 | 148 |
Pancreas | Pancreatic adenocarcinoma (PAAD) | 184 | 122 | 62 |
Prostate | Prostate adenocarcinoma (PRAD) | 498 | 329 | 169 |
Skin | Cutaneous melanoma (SKCM) | 104 | 69 | 35 |
Testis | Testicular germ cell tumors (TGCT) | 150 | 99 | 51 |
Thoracic | Lung adenocarcinoma (LUAD) | 1143 | 755 | 388 |
Lung squamous cell carcinoma (LUSC) | ||||
Mesothelioma (MESO) | ||||
Thyroid | Thyroid carcinoma (THCA) | 496 | 327 | 169 |
Uterus | Uterine carcinosarcoma (UCS) | 598 | 395 | 203 |
Uterine corpus endometrial carcinoma (UCEC) | ||||